Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
- First Posted Date
- 2012-12-13
- Last Posted Date
- 2014-06-19
- Lead Sponsor
- NeurAxon Inc.
- Target Recruit Count
- 188
- Registration Number
- NCT01748877
- Locations
- 🇺🇸
Premier Research, Phoenix, Arizona, United States
🇺🇸University of Southern California, Los Angeles, California, United States
🇺🇸Northern California Research, Sacramento, California, United States
Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura
- First Posted Date
- 2009-08-17
- Last Posted Date
- 2014-07-23
- Lead Sponsor
- NeurAxon Inc.
- Target Recruit Count
- 195
- Registration Number
- NCT00959751
- Locations
- 🇺🇸
Comprehensive Neuroscience, Inc., St. Petersburg, Florida, United States
🇺🇸Comprehensive NeuroScience, Inc. Atlanta, Atlanta, Georgia, United States
🇺🇸Elkind Headache Center, Mount Vernon, New York, United States
Study of NXN 188 for the Treatment of Migraine With Aura
- Conditions
- Migraine With Aura
- Interventions
- First Posted Date
- 2009-06-15
- Last Posted Date
- 2014-08-11
- Lead Sponsor
- NeurAxon Inc.
- Target Recruit Count
- 239
- Registration Number
- NCT00920686
- Locations
- 🇺🇸
C. Philip O'Carrroll, MD, Inc., Newport Beach, California, United States
🇺🇸The Research Center of Southern California, LLC, Oceanside, California, United States
🇺🇸San Francisco Headache Clinic, San Francisco, California, United States